HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Gne M712T mouse as a model for human glomerulopathy.

Abstract
Pathological glomerular hyposialylation has been implicated in certain unexplained glomerulopathies, including minimal change nephrosis, membranous glomerulonephritis, and IgA nephropathy. We studied our previously established mouse model carrying a homozygous mutation in the key enzyme of sialic acid biosynthesis, N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase. Mutant mice died before postnatal day 3 (P3) from severe glomerulopathy with podocyte effacement and segmental glomerular basement membrane splitting due to hyposialylation. Administration of the sialic acid precursor N-acetylmannosamine (ManNAc) led to improved sialylation and survival of mutant pups beyond P3. We determined the onset of the glomerulopathy in the embryonic stage. A lectin panel, distinguishing normally sialylated from hyposialylated glycans, used WGA, SNA, PNA, Jacalin, HPA, and VVA, indicating glomerular hyposialylation of predominantly O-linked glycoproteins in mutant mice. The glomerular glycoproteins nephrin and podocalyxin were hyposialylated in this unique murine model. ManNAc treatment appeared to ameliorate the hyposialylation status of mutant mice, indicated by a lectin histochemistry pattern similar to that of wild-type mice, with improved sialylation of both nephrin and podocalyxin, as well as reduced albuminuria compared with untreated mutant mice. These findings suggest application of our lectin panel for categorizing human kidney specimens based on glomerular sialylation status. Moreover, the partial restoration of glomerular architecture in ManNAc-treated mice highlights ManNAc as a potential treatment for humans affected with disorders of glomerular hyposialylation.
AuthorsSravan Kakani, Tal Yardeni, Justin Poling, Carla Ciccone, Terren Niethamer, Enriko D Klootwijk, Irini Manoli, Daniel Darvish, Shelley Hoogstraten-Miller, Patricia Zerfas, E Tian, Kelly G Ten Hagen, Jeffrey B Kopp, William A Gahl, Marjan Huizing
JournalThe American journal of pathology (Am J Pathol) Vol. 180 Issue 4 Pg. 1431-40 (Apr 2012) ISSN: 1525-2191 [Electronic] United States
PMID22322304 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
CopyrightCopyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Biomarkers
  • Carrier Proteins
  • Hexosamines
  • Membrane Proteins
  • Sialoglycoproteins
  • nephrin
  • podocalyxin
  • Carbohydrate Epimerases
  • N-acyl-D-glucosamine 2-epimerase
  • N-Acetylneuraminic Acid
  • N-acetylmannosamine
Topics
  • Animals
  • Biomarkers (metabolism)
  • Carbohydrate Epimerases (genetics)
  • Carrier Proteins (genetics)
  • Dietary Supplements
  • Disease Models, Animal
  • Drug Evaluation, Preclinical (methods)
  • Hexosamines (therapeutic use)
  • Humans
  • Kidney Diseases (drug therapy, genetics, metabolism, pathology)
  • Kidney Glomerulus (embryology, metabolism, ultrastructure)
  • Membrane Proteins (metabolism)
  • Mice
  • Mice, Mutant Strains
  • Microscopy, Electron
  • Mutation
  • N-Acetylneuraminic Acid (physiology)
  • Podocytes (metabolism, ultrastructure)
  • Real-Time Polymerase Chain Reaction (methods)
  • Sialoglycoproteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: